Subtopic Deep Dive
Boron Neutron Capture Therapy
Research Guide
What is Boron Neutron Capture Therapy?
Boron Neutron Capture Therapy (BNCT) is a binary radiotherapy that selectively destroys cancer cells by irradiating boron-10 compounds with thermal neutrons to produce high-LET alpha particles and lithium-7 nuclei.
BNCT relies on the 10B(n,α)7Li reaction with a path length of 5-9 μm matching cell dimensions (Barth et al., 2005, 1018 citations). Clinical applications target gliomas and head-and-neck cancers using boron delivery agents like carboranes (Barth et al., 2012, 502 citations). Over 10 key papers document preclinical and phase I/II trials since 1992.
Why It Matters
BNCT treats radioresistant tumors like high-grade gliomas where conventional radiotherapy fails, achieving complete response in recurrent head-and-neck cancer phase I/II trials (Kankaanranta et al., 2011, 256 citations). Accelerator-based neutron sources enable hospital integration, expanding access beyond nuclear reactors (Dymova et al., 2020, 294 citations; Suzuki, 2019, 275 citations). Boron delivery innovations, such as carborane-nanotube conjugates, improve tumor selectivity and therapeutic ratios (Zhu et al., 2005, 321 citations).
Key Research Challenges
Boron Delivery Selectivity
Achieving 10-35 μg 10B/g tumor with tumor:normal ratios >3:1 remains difficult due to poor vascular permeability. Carborane agents show promise but require further optimization (Barth et al., 2005). Nanotube conjugates enhance solubility yet face biocompatibility issues (Zhu et al., 2005).
Neutron Source Availability
Thermal neutron fluxes from reactors limit clinical scalability; accelerator-based sources need higher intensity. Recent advances support hospital BNCT but flux uniformity varies (Dymova et al., 2020). Dose modeling requires precise microdosimetry (Suzuki, 2019).
Pharmacokinetics Optimization
Boron agents must retain in tumors during irradiation windows of minutes. Clinical trials report variable uptake in gliomas (Barth et al., 2012). Real-time imaging and agent design address retention challenges (Barth et al., 2018).
Essential Papers
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
Rolf F. Barth, Jeffrey A. Coderre, M. Graça H. Vicente et al. · 2005 · Clinical Cancer Research · 1.0K citations
Abstract Background: Boron neutron capture therapy (BNCT) is based on the nuclear reaction that occurs when boron-10 is irradiated with low-energy thermal neutrons to yield high linear energy trans...
Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer
Rolf F. Barth, MGraca H Vicente, O. K. Harling et al. · 2012 · DOAJ (DOAJ: Directory of Open Access Journals) · 502 citations
<p>Abstract</p> <p>Boron neutron capture therapy (BNCT) is a biochemically targeted radiotherapy based on the nuclear capture and fission reactions that occur when non-radioactive...
Substituted Carborane-Appended Water-Soluble Single-Wall Carbon Nanotubes: New Approach to Boron Neutron Capture Therapy Drug Delivery
Yinghuai Zhu, Ang Thiam Peng, Keith Carpenter et al. · 2005 · Journal of the American Chemical Society · 321 citations
Substituted C(2)B(10) carborane cages have been successfully attached to the side walls of single-wall carbon nanotubes (SWCNTs) via nitrene cycloaddition. The decapitations of these C(2)B(10) carb...
Boron neutron capture therapy: Current status and future perspectives
М. А. Дымова, Sergey Yurjevich Taskaev, Vladimir A. Richter et al. · 2020 · Cancer Communications · 294 citations
Abstract The development of new accelerators has given a new impetus to the development of new drugs and treatment technologies using boron neutron capture therapy (BNCT). We analyzed the current s...
Boron neutron capture therapy for cancer. Realities and prospects
Rolf F. Barfh, Mark S. Soloway, Ralph G. Fairchild et al. · 1992 · Cancer · 291 citations
Boron neutron capture therapy (BNCT) is based on the nuclear reaction that occurs when a stable isotope, boron-10 (10B), is irradiated with low-energy thermal neutrons (nth) to yield (4He) alpha-pa...
Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era
Minoru Suzuki · 2019 · International Journal of Clinical Oncology · 275 citations
Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head-and-Neck Cancer: Final Analysis of a Phase I/II Trial
Leena Kankaanranta, Tiina Seppälä, Hanna Koivunoro et al. · 2011 · International Journal of Radiation Oncology*Biology*Physics · 256 citations
Reading Guide
Foundational Papers
Start with Barth et al. (2005, 1018 citations) for BNCT principles and reaction details; follow with Barth et al. (1992, 291 citations) for early realities and Barth et al. (2012, 502 citations) for glioma/head-neck clinical status.
Recent Advances
Study Dymova et al. (2020, 294 citations) for accelerator prospects; Barth et al. (2018, 237 citations) for realistic appraisals; Suzuki (2019, 275 citations) for accelerator-era transition.
Core Methods
Core techniques: 10B(n,α)7Li reaction dosimetry, BPA/BSH delivery agents, epithermal neutron beams, carborane conjugation to nanotubes (Barth et al., 2005; Zhu et al., 2005).
How PapersFlow Helps You Research Boron Neutron Capture Therapy
Discover & Search
Research Agent uses searchPapers('boron neutron capture therapy gliomas') to retrieve Barth et al. (2005, 1018 citations), then citationGraph reveals forward citations like Barth et al. (2012), and findSimilarPapers uncovers nanotube delivery (Zhu et al., 2005). exaSearch('accelerator-based BNCT') finds Dymova et al. (2020).
Analyze & Verify
Analysis Agent applies readPaperContent on Barth et al. (2005) to extract 10B uptake data, verifyResponse with CoVe cross-checks claims against Suzuki (2019), and runPythonAnalysis simulates α-particle dosimetry using NumPy for path length distributions. GRADE grading scores clinical evidence from Kankaanranta et al. (2011) as moderate due to phase I/II limitations.
Synthesize & Write
Synthesis Agent detects gaps in boron selectivity across Barth et al. (2005) and Zhu et al. (2005), flags contradictions in neutron flux requirements (Dymova et al., 2020 vs. Barth et al., 2012). Writing Agent uses latexEditText for BNCT mechanism diagrams, latexSyncCitations integrates 10 papers, and latexCompile generates a review manuscript; exportMermaid visualizes reaction pathways.
Use Cases
"Analyze boron uptake data from BNCT glioma trials and plot tumor:normal ratios."
Research Agent → searchPapers → Analysis Agent → readPaperContent(Barth 2012) + runPythonAnalysis(pandas plot ratios from extracted tables) → matplotlib figure of therapeutic ratios vs. time.
"Write a LaTeX review section on accelerator BNCT with citations and dosimetry diagram."
Synthesis Agent → gap detection → Writing Agent → latexEditText('BNCT accelerators') → latexSyncCitations(5 papers) → latexCompile → exportMermaid(neutron flux diagram).
"Find code for BNCT microdosimetry simulations from recent papers."
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis on dosimetry scripts for α-particle track verification.
Automated Workflows
Deep Research workflow scans 50+ BNCT papers via searchPapers, structures a systematic review report with GRADE-scored evidence from Barth et al. (2005) and clinical trials. DeepScan applies 7-step CoVe analysis to verify boron delivery claims in Zhu et al. (2005) against pharmacokinetics data. Theorizer generates hypotheses for carborane-nanotube optimizations from literature patterns.
Frequently Asked Questions
What defines Boron Neutron Capture Therapy?
BNCT uses 10B irradiation with thermal neutrons to produce localized α particles and 7Li nuclei destroying cancer cells (Barth et al., 2005).
What are key BNCT methods?
Methods include boronophenylalanine (BPA) infusion for gliomas and epithermal neutron beams; carborane nanotubes enhance delivery (Zhu et al., 2005; Barth et al., 2012).
What are landmark BNCT papers?
Barth et al. (2005, 1018 citations) reviews principles; Kankaanranta et al. (2011, 256 citations) reports phase II head-neck trial results.
What open problems exist in BNCT?
Challenges include boron tumor selectivity >3:1, accelerator neutron flux scaling, and real-time dosimetry (Dymova et al., 2020; Barth et al., 2018).
Research Boron Compounds in Chemistry with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Boron Neutron Capture Therapy with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Boron Compounds in Chemistry Research Guide